Navigation Links
Spinal cement may provide real support for cancer patients
Date:1/12/2010

New technologies used to repair spinal fractures could soon be helping patients suffering from the bone marrow cancer multiple myeloma.

A research project led by engineers at the University of Leeds will focus on the disease an incurable cancer of the bone marrow that causes destructive lesions in bones and makes them more susceptible to fracture.

The study will analyse whether techniques such as injecting cements into the spine to stabilise the bone, or using plates to fix fractures can be adapted for affected patients.

Although incurable, improvements in treatment mean that patients with multiple myeloma are surviving for longer, with up to a third surviving for at least five years. However, a better prognosis means that secondary symptoms, such as painful bone deterioration, have more time to take effect.

"Our aim is to give people suffering from this disease a better quality of life. If the spine becomes weakened or fractures, patients can do little more than stay in bed and try to deal with the pain," said Professor of Spinal Biomechanics, Richard Hall, who is leading the research at Leeds' Faculty of Engineering. "The majority of multiple myeloma patients are in their sixties or older, but even simple things that we take for granted, such as sitting your grandchild on your knee, can become impossible for them."

The work will combine laboratory experiments with computer modelling to predict the impacts of various treatments on patients.

Professor Hall will be collaborating with researchers at the Sunnybrook Health Sciences Centre, housed at one of Canada's largest hospitals in Toronto, and clinicians from Leeds Teaching Hospitals NHS Trust.

The project team includes Mr Jake Timothy, Consultant Neurosurgeon in Leeds, who has developed an award winning clinical vertebroplasty and kyphoplasty service that can help to fix painful vertebrae and spinal compression fractures associated with osteoporosis. He has seen the dramatic improvement that such procedures can have on the pain scores of patients affected by vertebral myeloma.

"There is still so much unknown about the positive and negative effects of these procedures," he says. "This money will undoubtedly aid our understanding and help us select which patients will benefit the most from these procedures, improving their quality of life even further."

The 600,000 project has been funded through the Engineering and Physical Sciences Research Council (EPSRC) and will run for four years. The work is part of the 50M research portfolio led by the Institute of Medical and Biological Engineering (iMBE) aimed at giving people '50 active years after 50'.

Professor Hall is also leading a 3 million EU-funded research project involving academic and industrial partners from Germany and Austria, looking at new ways of diagnosing and treating spinal fracture caused not only by disease, but by age and trauma.


'/>"/>

Contact: Profssor Richard Hall
r.m.hall@leeds.ac.uk
44-113-343-2132
University of Leeds
Source:Eurekalert

Related medicine news :

1. Cialis Eases Erectile Dysfunction After Spinal Cord Injury
2. Summit on Spinal Muscular Atrophy
3. New Low-Back Pain Guidelines Should Encourage Patients to Utilize Spinal Manipulation
4. Pioneer Surgical Technology Hires New Spinal Franchise Manager
5. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
6. Mayo Clinic clarifies diagnosis for serious blood vessel disease of brain and spinal cord
7. Spinal cord injury expert to be honored by research foundation
8. ArthroCare Releases New SpineWand(R) for Less Invasive Spinal Surgeries
9. Engineers developing new cements to heal spinal fractures
10. Polyanalgesic Consensus Panels New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain
11. Jefferson researchers find stem cells in degenerating spinal discs, potential for repair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: